1. Klawiter EC, Cross AH. B cells: No longer the nondominant arm of multiple sclerosis. Curr Neurol Neurosci Rep. 2007;7:231-238. [PubMed]

2. Oh S, Cudrici C, Ito T, et al. B-cells and humoral immunity in multiple sclerosis. Implications for therapy. Immunol Res. 2008;40:224-234. [PubMed]

3. Nikbin B, Bonab MM, Khosravi F, et al. Role of B cells in pathogenesis of multiple sclerosis. Int Rev Neurobiol. 2007;79:13-42. [PubMed]

4. Antel J, Bar-Or A. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment. J Neuroimmunol. 2006;180:3-8. [PubMed]

5. Magliozzi R, Howell O, Vora A, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007;130:1089-1104. [PubMed]

6. McFarland HF. The B cell—old player, new position on the team. N Engl J Med. 2008;358:664-665. [PubMed]

7. Duddy ME, Alter A, Bar-Or A. Distinct profiles of human B cell effector cytokines: a role in immune regulation? J Immunol. 2004;172:3422-3427. [PubMed]

8. Lund FE, Garvy BA, Randall TD, Harris DP. Regulatory roles for cytokineproducing B cells in infection and autoimmune disease. Curr Dir Autoimmun. 2005;8:25-54. [PubMed]

9. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol. 2006; 176:705-710. [PubMed]

10. Bar-Or A, Niino M, Duddy M, et al. Abnormal B cell cytokine response in multiple sclerosis points to distinct roles for naive and memory human B cells in human regulation. Clin Immunol. 2006;119:S26-S27.

11. Lorenz RG, Chaplin DD, McDonald KG, et al. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient b lymphocytes, lymphotoxin‚ receptor and TNF receptor I function. J Immunol. 2003;170:5475-5482. [PubMed]

12. Andersson L, Boling M, Wirestam R, Holtås S, Ståhlberg F. Combined diffusion weighting and CSF suppression in functional MRI. NMR Biomed. 2002;15:235-240. [PubMed]

13. Link H, Huang Y-M. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol. 2007;180:17-28. [PubMed]

14. Sidén A. Isoelectric focusing and crossed immunoelectrofocusing of CSF immunoglobulins in MS. J Neurol. 1979;221:39-51. [PubMed]

15. Owens GP, Bennett JL, Gilden DH, et al. The B cell response in multiple sclerosis. Neurol Res. 2006;28:236-244. [PubMed]

16. Corcione A, Casazza S, Ferretti E, et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci USA. 2004;101:11064-11069. [PubMed]

17. Uccelli A, Aloisi F, Pistoia V. Unveiling the enigma of the CNS as a B-cell fostering environment. Trends Immunol. 2005;26:254-259. [PubMed]

18. Cepok S, Rosche B, Brummel V, et al. Short lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain. 2005;128:1667-1676. [PubMed]

19. Cepok S, von Geldern G, Grummel V, et al. Accumulation of class switched IgD-IgM-memory B cells in the cerebrospinal fluid during neuroinflammation. J Neuroimmunol. 2006;180:33-39. [PubMed]

20. Qin Y, Duquette P, Zhang Y, et al. Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis. Lab Invest. 2003;83:1081-1088.[PubMed]

21. Esiri MM. Immunoglobulin-containing cells in multiple sclerosis plaques. Lancet. 1977;2:478-480.[PubMed]

22. Prineas JW, Wright RG. Macrophages, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest. 1978; 38:409-421.[PubMed]

23. Raine CS, Cannella B, Hauser SL, et al. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann Neurol. 1999;46:144-160.[PubMed]

24. Knezevic-Maramica I, Kruskall MS. Intravenous immune globulins: an update for clinicians. Transfusion. 2003;43:1460-1480.[PubMed]

25. Lemieux R, Bazin R, Neron S. Therapeutic intravenous immunoglobulins. Mol Immunol. 2005;42:839-848.[PubMed]

26. Bar-Or A, Nuttall RK, Duddy M, et al. Analyses of all matrix metalloproteinase members in leukocytes: monocytes as major inflammatory mediators in multiple sclerosis. Brain. 2003;126:2738-2749.[PubMed]

27. Alter A, Duddy M, Hebert S, et al. Determinants of human B cell migration across brain endothelial cells. J Immunol. 2003;170:4497-4505.[PubMed]

28. Niino N, Bodner C, Simard ML, et al. Effects of natalizumab on immune responses in multiple sclerosis. Ann Neurol. 2006;59:748-754.[PubMed]

29. Reff ME, Carner K, Chambers KS, et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood. 1994;83:435-445.[PubMed]

30. Anderson DR, Grillo-López A, Varns C, et al. Targeted anticancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin’s B-cell lymphoma. Biochem Soc Trans. 1997;25:705-708.[PubMed]

31. Clynes RA. Towers TL, Presta LG, et al. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat Med. 2000;6:443-446.[PubMed]

32. Hauser SL, Waubant E, Arnold DL, et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med. 2008;358:676-688[PubMed]

33. Cross AH, Stark JL, Lauber J, et al. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol. 2006;180:63-70.[PubMed]

34. Bar-Or A, Waubant E, Ren S, Sarkar N, Smith C. Pharmacokinetics and pharmacodynamics of rituximab in adults with RRMS in a 48-week phase II placebo-controlled multicenter trial. Presented at the Annual Meeting of the American Academy of Neurology, Chicago, Illinois, 2008.

35. FDA Public Health Advisory. Life-threatening brain infection in patients with systemic lupus erythematosus after Rituxan (rituximab) treatment. Available at: http://fda.gov/Cder/Drug/advisory/rituximab.htm. Accessed April 18, 2008.

36. Rituxan® (rituximab) prescribing information. 2008. Available at: http://www.gene.com/gene/products/information/pdf/rituxan-prescribing.pdf. Accessed April 18, 2008.